Report cover image

AI in Biotechnology: Global Markets

Publisher BCC Research
Published Aug 27, 2025
Length 142 Pages
SKU # WA20408097

Description

Report Scope

The report analyzes the trends in the global market for AI in biotechnology. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented by product type (software and services), deployment (cloud-based and on-premises), application and end user. Applications consist of drug discovery, clinical trials, diagnostics and others. End users consist of pharmaceutical and biotech companies, academic research institutes, contract R&D organizations (CROs/CDMOs) and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the Rest of Europe, China, Japan, India, South Korea and the Rest of Asia-Pacific.

The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. It offers company profiles that covers such details as financials, product portfolio and recent developments. It analyzes companies’ environmental, social and corporate governance (ESG) initiatives.

Report Includes
  • 50 data tables and 57 additional tables
  • An analysis of the current and future global markets for artificial intelligence (AI) in biotechnology
  • Analyses of the global market trends, with historic revenue data (sales figures) from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
  • Estimates of the size of the market and revenue prospects, along with a corresponding market share analysis based on product type, application, deployment type, end user, and region
  • Facts and figures pertaining to market dynamics, technological advancements, regulations, prospects and the impact of macroeconomic variables
  • Discussion of the underlying opportunities and potential, with the development of novel products, drug discovery, clinical trials and other related applications
  • Insights derived from Porter’s Five Forces model and global supply chain analyses
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Profiles of the leading companies, including NVIDIA Corp., Tempus AI Inc., Recursion Pharmaceuticals, Schrödinger Inc., and Sophia Genetics


Companies Mentioned

Abcellera Biologics Inc.
Absci Corp.
Atomwise Inc.
Benevolentai
Dnanexus Inc.
Eurofins Scientific
Illumina Inc.
Insilico Medicine
Nvidia Corp.
Qiagen
Recursion
Schrodinger Inc.
Sophia Genetics
Tempus Ai Inc.
Xtalpi Inc.

Table of Contents

142 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Market Insights
Emerging Technologies
Conclusion
Chapter 2 Market Overview
Overview
Potential Applications of AI in Biotechnology
Use Cases
Use Case 1: Drug Discovery
Use Case 2: Personalized Medicine
AI's Impact on the Biotech Value Chain
Macroeconomic Factors Analysis
Demographic Factors
Geopolitical Factors
Impact of U.S. Tariffs
Porter's Five Forces Analysis
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Need for More Effective Drug Discovery and Development Process
Shift to Personalized Medicine
Growing Demand for Effective and Early Diagnosis
Rising Investments in AI in Biopharmaceuticals
Aging Population and the Growing Prevalence of Chronic Diseases
Market Restraints
Data Quality and Bias
Integration Hurdles
Ethical Concerns
Market Opportunities
AI in Synthetic Biology
Convergence of AI and Quantum Computing
Chapter 4 Regulatory Landscape
Regulatory Scenario
United States
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Developments
Emerging Trends/Technologies
Key Takeaways
Agentic AI
Generative AI
Federated Learning
Advanced Neural Networks
Chapter 6 Market Segmentation Analysis
Overview
Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Software
Services
Market Analysis by Deployment Type
Key Takeaways
Cloud-based
On-premises
Market Analysis by Application
Key Takeaways
Drug Discovery
Clinical Trials and Optimization
Diagnostics
Other Applications
Market Analysis by End User
Key Takeaways
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Manufacturing and Development Organizations
Other End Users
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Analysis
Strategic Initiatives
Mergers and Acquisitions
Agreements, Collaborations and Partnerships
Investment Landscape
Chapter 8 Sustainability in AI in Biotechnology Market: An ESG Perspective
Introduction to ESG
Sustainability Trends and Company Initiatives
ESG Risk Ratings
Concluding Remarks
Chapter 9 Appendix
Research Methodology
Sources
Abbreviations
Company Profiles
ABCELLERA BIOLOGICS INC.
ABSCI CORP.
ATOMWISE INC.
BENEVOLENTAI
DNANEXUS INC.
EUROFINS SCIENTIFIC
ILLUMINA INC.
INSILICO MEDICINE
NVIDIA CORP.
QIAGEN
RECURSION
SCHRODINGER INC.
SOPHIA GENETICS
TEMPUS AI INC.
XTALPI INC.
Other Emerging Companies in the Market
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.